Skip to main content

Bovilis Vista 5 L5 SQ CFP

This page contains information on Bovilis Vista 5 L5 SQ CFP for veterinary use.
The information provided typically includes the following:
  • Bovilis Vista 5 L5 SQ CFP Indications
  • Warnings and cautions for Bovilis Vista 5 L5 SQ CFP
  • Direction and dosage information for Bovilis Vista 5 L5 SQ CFP

Bovilis Vista 5 L5 SQ CFP

This treatment applies to the following species:
Company: Intervet/Merck Animal Health

Bovine Rhinotracheitis-Virus Diarrhea-Parainfluenza 3-Respiratory Syncytial Virus Vaccine, Modified Live Virus, Leptospira Canicola-Grippotyphosa-Hardjo-Icterohaemorrhagiae-Pomona-Bacterin

Cattle Vaccine

This product has been shown effective for the vaccination of healthy cattle 6 months of age or older against respiratory disease and abortion due to infectious bovine rhinotracheitis (IBR), respiratory disease and fetal infection, including persistently infected calves due to bovine virus diarrhea virus (BVD) Types 1 & 2, bovine respiratory syncytial virus (BRSV) and parainfluenza3 virus (PI3) and leptospirosis (caused by Leptospira canicola, L. grippotyphosa, L. hardjo - including the L. borgpetersenii serovar hardjo bovis, L. icterohaemorrhagiae, and L. pomona). Reproductive Duration of immunity has been shown to be at least 217 days for IBR and at least 206 days for BVD (Types 1 & 2). Respiratory Duration of immunity has been demonstrated to be at least 182 days for IBR, and at least 206 days for BVD Type 1 and at least 200 days for BVD Type 2. Duration of immunity for BRSV, PI3 and Leptospira spp. has not been established. For more information regarding efficacy and safety data, go to productdata.aphis.usda.gov.

Respiratory and reproductive efficacy and duration of immunity has been demonstrated against disease caused by the BVD Type 1b strain.

This product has been shown to be effective against urinary shedding of L. hardjo organisms.

SAFETY: Safe for use in pregnant heifers and cows or calves nursing pregnant cows provided the cows and heifers in the herd are vaccinated prior to breeding, within the previous 12 months, with any of the modified live IBR and BVD containing vaccine(s) in this product line.

MIXING DIRECTIONS: Rehydrate freeze dried vial of Vista® 5 with accompanying vial of L5 SQ. Mix reconstituted vial well.

USE DIRECTIONS: Administer a single 2.0 mL dose aseptically by the subcutaneous route 14-60 days prior to breeding. Historically, annual revaccination with this product has been recommended. The need for this booster has not been established. For more information on revaccination frequency, consult your veterinarian.

Mixing Instructions

CAUTION: THE TRANSFER NEEDLE, INCLUDED IN THE CARTON PACKAGING (50 DOSES), IS SHARP AND MAY CAUSE INJURY TO SELF OR ANIMALS IF NOT HANDLED OR DISPOSED OF PROPERLY.

1. Insert the transfer needle fully into the small vial of dehydrated vaccine to release the vacuum.

2. Insert the other end of the transfer needle fully into the large vial of sterile diluent.

3. Squeeze enough diluent from the large bottle into the smaller vial to rehydrate the vaccine.

4. With the two bottles still attached, swirl the small vial gently until the vaccine is mixed.

5. With the small vial upside down, squeeze the large bottle several times to draw the mixed vaccine into the large bottle.

6. Separate the bottles and remove the vaccine label from the small vial and apply it to the large bottle for proper identification.

CAUTIONS: Store at 2 to 8°C (35 to 46°F). Fetal health risks associated with the vaccination of pregnant animals with this vaccine cannot be unequivocally determined during clinical trials conducted for licensure. Appropriate strategies to address the risks associated with vaccine use in pregnant animals should be discussed with a veterinarian. Do not freeze. Use entire contents when first opened. Do not use chemical disinfectants to sterilize syringes or needles. Do not mix with other products, except as specified on the label. Inactivate unused contents before disposal. Do not vaccinate within 21 days of slaughter. Anaphylactoid reactions may occur following use. Antidote: Epinephrine. Contains penicillin, streptomycin, and thimerosal as preservatives. In case of human exposure, contact a physician.

FOR ANIMAL USE ONLY

Intervet Inc., d/b/a Merck Animal Health, Omaha, NE 68103 USA

VLN 165A/PCN 4461.22

1-800-521-5767

For patent information:

http://www.merck.com/product/patent/home.html

 

 

 

Code

 

10 mL

5 Doses

2 mL per dose

006343

364636-08

20 mL

10 Doses

006344

362020-08

100 mL

50 Doses

006345

365562-08

CPN: 1047579.0

MERCK ANIMAL HEALTH
Intervet Inc.

126 E. LINCOLN AVENUE, PO BOX 2000, Rahway, NJ, 07065
Customer Service:   800-521-5767
Technical Service (Companion Animal):   800-224-5318
Technical Service (Livestock):   800-211-3573
Website:   www.merck-animal-health-usa.com
THIS SERVICE AND DATA ARE PROVIDED "AS IS". DVMetrics assumes no liability, and each user assumes full risk, responsibility, and liability, related to its use of the DVMetrics service and data. See the Terms of Use for further details.

Copyright © 2024 Animalytix LLC. Updated: 2024-02-27